JPMorgan Equity Premium Income ETF delivers consistent monthly income with a 7-8% yield, though it lags the broader market's ...

Today’s edition tracks the rupee hitting a record low, India’s energy-transition imperatives, Delhi’s air quality emergency, ...

Wall Street trading got off to a mixed start on Friday after both the Dow Jones and S&P 500 wrapped up the previous session ...

After a tentative start, US stocks rallied following the Federal Reserve's decision to lower interest rates, with the S&P 500 ...

Partnering Platform Now Open for RegistrationSAN FRANCISCO--(BUSINESS WIRE)--#biotechshowcase--Biotech Showcase™ returns to ...

SAN FRANCISCO, CA / ACCESS Newswire / December 9, 2025 / Longwood Healthcare Leaders will convene top biopharmaceutical leaders at San Francisco CEO for two days of discussion, January 10-11, 2026, ...

Fintel reports that on December 4, 2025, Canaccord Genuity maintained coverage of Regeneron Pharmaceuticals (NasdaqGS:REGN) ...

Fintel reports that on December 3, 2025, Morgan Stanley downgraded their outlook for Regeneron Pharmaceuticals (NasdaqGS:REGN ...

Morgan Stanley has downgraded Regeneron Pharmaceuticals ( REGN) to equal-weight from overweight saying that the stock is fairly valued. The bank maintained its price target of $767 (~3% upside based ...

Detailed price information for Vera Therapeutics Inc Cl A (VERA-Q) from The Globe and Mail including charting and trades.

Bitcoin (BTC) could climb to $240,000 over the long term, according to a recent JPMorgan note assessing the asset’s evolving market structure. The projection followed a weak stretch for the broader ...

Regeneron Pharmaceuticals and Sanofi have won European Commission expanded approval of their blockbuster anti-inflammatory drug Dupixent for certain patients with the inflammatory skin condition ...